{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T15:09:28Z","timestamp":1767971368780,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"crossref","award":["1037196"],"award-info":[{"award-number":["1037196"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.jad.2017.12.022","type":"journal-article","created":{"date-parts":[[2017,12,12]],"date-time":"2017-12-12T03:44:45Z","timestamp":1513050285000},"page":"216-221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Is there consensus across international evidence-based guidelines for the psychotropic drug management of bipolar disorder during the perinatal period?"],"prefix":"10.1016","volume":"228","author":[{"given":"Rebecca K.","family":"Graham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Tavella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon B.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2017.12.022_bib1","series-title":"Guideline Watch for the Practice Guideline for the Treatment of Patients with Bipolar Disorder","author":"American Psychiatric Association","year":"2005"},{"issue":"Suppl 4","key":"10.1016\/j.jad.2017.12.022_bib2","first-page":"S1","article-title":"Practice guideline for the treatment of patients with bipolar disorder","volume":"159","author":"American Psychiatric Association","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2017.12.022_bib3","first-page":"890","article-title":"Management of bipolar disorder over the perinatal period","volume":"45","author":"Boyce","year":"2016","journal-title":"Aust. Fam. Physician"},{"key":"10.1016\/j.jad.2017.12.022_bib4","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1176\/appi.ajp.2013.13010006","article-title":"Lamotrigine dosing for pregnant patients with bipolar disorder","volume":"170","author":"Clark","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2017.12.022_bib5","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.eurpsy.2011.06.011","article-title":"The management of bipolar disorder in the perinatal period and risk factors for postpartum relapse","volume":"27","author":"Doyle","year":"2012","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.jad.2017.12.022_bib6","unstructured":"Food and Drug Administration, 2006. Information for Healthcare Professionals: Lamotrigine (Marketed as Lamictal). \u3008https:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProvPostm\/ucm126225.htm\u3009. (Accessed 2 March 2016)."},{"key":"10.1016\/j.jad.2017.12.022_bib7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3109\/00048670903487217","article-title":"Management of antipsychotic and mood stabilizer medication in pregnancy: recommendations for antenatal care","volume":"44","author":"Galbally","year":"2010","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.jad.2017.12.022_bib8","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/0269881109102919","article-title":"Evidence-based guidelines for treating bipolar disorder, revised second edition: recommendations from the British Association for Psychopharmacology","volume":"23","author":"Goodwin","year":"2009","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2017.12.022_bib9","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1001\/jama.2016.19969","article-title":"Clinical practice guidelines: expanded use and misuse","volume":"317","author":"Greenfield","year":"2017","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.jad.2017.12.022_bib10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/15622970902823202","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania","volume":"10","author":"Grunze","year":"2009","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2017.12.022_bib11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/15622970903555881","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update2010 on the treatment of acute bipolar depression","volume":"11","author":"Grunze","year":"2010","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2017.12.022_bib12","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3109\/15622975.2013.770551","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar depression","volume":"14","author":"Grunze","year":"2013","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2017.12.022_bib13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0165-0327(95)00006-9","article-title":"Does puerperal illness distinguish a subgroup of bipolar patients?","volume":"34","author":"Hunt","year":"1995","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2017.12.022_bib14","series-title":"Clinical Practice Guidelines We Can Trust","author":"Institute of Medicine","year":"2011"},{"key":"10.1016\/j.jad.2017.12.022_bib15","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/1468-0009.12210","article-title":"The mass production of redundant, misleading, and conflicted systematic reviews and meta-analyses","volume":"94","author":"Ioannidis","year":"2016","journal-title":"Milibank Q."},{"key":"10.1016\/j.jad.2017.12.022_bib16","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/pcn.12060","article-title":"Guideline for treatment of bipolar disorder by the Japanese Society of Mood Disorders","volume":"67","author":"Kanba","year":"2013","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2017.12.022_bib17","doi-asserted-by":"crossref","first-page":"f3830","DOI":"10.1136\/bmj.f3830","article-title":"Why we can\u2019t trust clinical guidelines","volume":"346","author":"Lenzer","year":"2013","journal-title":"Br. Med. J."},{"key":"10.1016\/j.jad.2017.12.022_bib18","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1517\/14740338.2011.583917","article-title":"Antidepressant use in pregnancy","volume":"10","author":"Lorenzo","year":"2011","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.jad.2017.12.022_bib19","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1177\/0004867415617657","article-title":"Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders","volume":"49","author":"Mahli","year":"2015","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.jad.2017.12.022_bib20","series-title":"VA\/DoD Clinical Practice Guideline for Management of Bipolar Disorder in Adults","author":"Management of Bipolar Disorder Working Group","year":"2010"},{"key":"10.1016\/j.jad.2017.12.022_bib21","unstructured":"National Institute for Health and Care Excellence, 2014. Antenatal and Postnatal Mental Health: Clinical Management and Service Guidance. \u3008https:\/\/www.nice.org.uk\/guidance\/cg45\u3009. (Accessed 12 May 2016)."},{"key":"10.1016\/j.jad.2017.12.022_bib22","series-title":"Therapeutic Guidelines: Psychotropics Version 6","author":"Norquay","year":"2008"},{"key":"10.1016\/j.jad.2017.12.022_bib23","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1056\/NEJMoa1612222","article-title":"Lithium use in pregnancy and the risk of cardiac malformations","volume":"376","author":"Patorno","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jad.2017.12.022_bib24","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s00228-014-1738-2","article-title":"Drug-induced adverse reactions via breastfeeding: a descriptive study in the French Pharmacovigilance Database","volume":"70","author":"Soussan","year":"2014","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.jad.2017.12.022_bib25","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1176\/appi.ajp.2011.11010148","article-title":"Episodes of mood disorders in 2,252 pregnancies and postpartum periods","volume":"168","author":"Viguera","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2017.12.022_bib26","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1176\/appi.ajp.2007.06101639","article-title":"Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation","volume":"164","author":"Viguera","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2017.12.022_bib27","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/OGX.0000000000000369","article-title":"Psychopharmacotherapy in pregnancy and breastfeeding","volume":"71","author":"Vitale","year":"2016","journal-title":"Obstet. Gynecol. Surv."},{"key":"10.1016\/j.jad.2017.12.022_bib28","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1176\/appi.ajp.2015.15010124","article-title":"Risk of postpartum relapse in bipolar disorder and postpartum psychosis: a systematic review and meta-analysis","volume":"173","author":"Wesseloo","year":"2015","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2017.12.022_bib29","series-title":"Pharmacological Treatment of Mental Disorders in Primary Health Care","author":"World Health Organisation","year":"2009"},{"key":"10.1016\/j.jad.2017.12.022_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/bdi.12025","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013","volume":"15","author":"Yatham","year":"2013","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2017.12.022_bib31","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1176\/appi.ajp.161.4.608","article-title":"Management of bipolar disorder during pregnancy and the postpartum period","volume":"161","author":"Yonkers","year":"2004","journal-title":"Am. J. Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032717318633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032717318633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T00:02:19Z","timestamp":1547683339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032717318633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":31,"alternative-id":["S0165032717318633"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2017.12.022","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is there consensus across international evidence-based guidelines for the psychotropic drug management of bipolar disorder during the perinatal period?","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2017.12.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}